UK-based GW Pharmaceuticals’ Epidiolex looks on course for approval in the US, after a panel of FDA experts unanimously backed it as a treatment for two rare forms of epilepsy. The FDA's ...

GW Pharma is to begin phase 3 trials of its epilepsy drug Epidiolex (cannabidiol) as an adjunctive therapy for the rare disease Tuberous Sclerosis Complex, following its recent late stage success ...

Sometimes, Journee has seizures, and her prescription includes “thick liquid Epidiolex,” Benns said, emphasizing the importance to consult medical professionals before giving a child any CBD ...

The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders.